STOCK TITAN
  1. Home
  2. DBTX

Decibel Therapeutics Stock Price, News & Analysis

DBTX NASDAQ

Company Description

Decibel Therapeutics (NASDAQ: DBTX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

DBTX stock has declined 100.0% over the past year.

This page provides a comprehensive overview of DBTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-100%
Performance 1 year
$0.0
Market Cap
25.1M
Shares outstanding

Decibel Therapeutics (DBTX) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All
August 11, 2023
-0.97%

Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update

earnings
June 2, 2023
-0.24%

Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference

conferences
June 1, 2023
-0.24%

Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

conferences clinical trial
May 17, 2023
+4.52%

Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit

conferences
May 15, 2023
+4.71%

Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update

earnings
May 12, 2023
+1.12%

Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO

clinical trial

Decibel Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, clinical trial, management. View all DBTX news →

SEC Filings

View All

No SEC filings available for DBTX.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

DBTX Company Profile & Sector Positioning

Decibel Therapeutics (DBTX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.